Found 460 results in Expert Content

Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications.

Summary: Lipid-based drug delivery systems have found widespread acceptance for development of drug products containing developability challenged APIs.

Summary: Orphan drugs face obstacles that span from discovery to launch, largely because of small patient populations and limited markets for rare disease therapies.

Summary: OneXpress® is a single integrated solution that provides the fastest pathway from clinical to commercial manufacturing.

Summary: This infographic focuses on evolving technologies that help overcome bioavailability challenges enabling the formulation of more complex molecules.

Summary: OptiDose Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders.

Read this case study to learn how a team of bioavailability experts at Catalent took a target molecule from early stage to Phase 1 in under nine months.

Explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung regions.

Summary: This infographic provides a high level summary of studies comparing Zydis ODT against traditional oral tablets.

Summary: In this webinar, learn more about enabling micronization of potent and highly potent compounds across the different stages of oral drug development